Home › CYIENT › Filing
🔔 Get instant alerts when CYIENT files quarterly results on BSE Start free trial →
Cyient Limited (CYIENT)

Investor Presentation

Filed: 22 Oct 2026, 16:29 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Cyient Group revenue $233.9M in Q2FY27, +7% QoQ and +15% YoY in INR - DET segment revenue $174.2M, +7% QoQ; EBIT margin improved to 14.2% - Semiconductor revenue $19.3M, +8% QoQ; EBIT loss narrowed slightly - Order book strong with book-to-bill ratio 1.6x, supporting revenue visibility - Interim dividend declared at ₹12 per share - Growth led by Aerospace, Industrial, Defense, and Medical segments - Investments in AI, semiconductors, and R&D to drive future revenue - CEO highlights integration of TAO Digital to enhance AI and data engineering - Management confident of navigating near-term headwinds with sustainable growth
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 CYIENT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add CYIENT to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Cyient Limited

Important. The summary above is generated automatically from Cyient Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.